Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Interference with islet-specific homing of autoreactive T cells: an emerging therapeutic strategy for type 1 diabetes.

Savinov AY, Burn P.

Drug Discov Today. 2010 Jul;15(13-14):531-9. doi: 10.1016/j.drudis.2010.05.013. Review.

PMID:
20685342
2.

Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.

Ludwig B, Barthel A, Reichel A, Block NL, Ludwig S, Schally AV, Bornstein SR.

Vitam Horm. 2014;95:195-222. doi: 10.1016/B978-0-12-800174-5.00008-9. Review.

PMID:
24559919
4.

Prevention of type 1 diabetes.

Rabinovitch A, Skyler JS.

Med Clin North Am. 1998 Jul;82(4):739-55. Review.

PMID:
9706119
5.

The role of cell adhesion molecules in the development of IDDM: implications for pathogenesis and therapy.

Yang XD, Michie SA, Mebius RE, Tisch R, Weissman I, McDevitt HO.

Diabetes. 1996 Jun;45(6):705-10. Review.

PMID:
8635641
6.

Autoimmune destruction of pancreatic beta cells.

Yoon JW, Jun HS.

Am J Ther. 2005 Nov-Dec;12(6):580-91. Review.

PMID:
16280652
7.

Role of beta-cells in type 1 diabetes pathogenesis.

Faideau B, Larger E, Lepault F, Carel JC, Boitard C.

Diabetes. 2005 Dec;54 Suppl 2:S87-96. Review.

8.

beta-Cell death during progression to diabetes.

Mathis D, Vence L, Benoist C.

Nature. 2001 Dec 13;414(6865):792-8. Review.

PMID:
11742411
9.

Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.

Yoon JW, Jun HS.

Ann N Y Acad Sci. 2001 Apr;928:200-11. Review.

PMID:
11795511
10.

Molecular mechanisms of pancreatic beta-cell destruction in autoimmune diabetes: potential targets for preventive therapy.

Iwahashi H, Itoh N, Yamagata K, Imagawa A, Nakajima H, Tomita K, Moriwaki M, Waguri M, Yamamoto K, Miyagawa J, Namba M, Hanafusa T, Matsuzawa Y.

Cytokines Cell Mol Ther. 1998 Mar;4(1):45-51. Review.

PMID:
9557216
12.

Type 1 diabetes mellitus: an imbalance between effector and regulatory T cells?

Rashba EJ, Reich EP, Janeway CA, Sherwin RS.

Acta Diabetol. 1993;30(2):61-9. Review.

PMID:
8219259
13.

Autoimmune tolerance and type 1 (insulin-dependent) diabetes mellitus.

Nossal GJ, Herold KC, Goodnow CC.

Diabetologia. 1992 Dec;35 Suppl 2:S49-59. Review.

PMID:
1478378
14.

Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.

Durinovic-Belló I.

Autoimmunity. 1998;27(3):159-77. Review.

PMID:
9609134
15.

Involvement of oxidative stress in the pathogenesis of diabetes.

Kaneto H, Katakami N, Kawamori D, Miyatsuka T, Sakamoto K, Matsuoka TA, Matsuhisa M, Yamasaki Y.

Antioxid Redox Signal. 2007 Mar;9(3):355-66. Review.

PMID:
17184181
16.
17.

[Interleukin-1 and nitric oxide involved in the pathogenesis of diabetes)].

Sjöholm A.

Lakartidningen. 1999 May 12;96(19):2338-41. Review. Swedish.

PMID:
10377681
18.

Etiology and pathogenesis of type 1 diabetes.

Scherbaum WA.

Horm Metab Res Suppl. 1992;26:111-6. Review.

PMID:
1490674
19.
20.

Modulation of insulin-dependent diabetes mellitus (IDDM) in NOD mice by autoreactive T cells.

Chaturvedi P, Qin HY, Chou H, Singh B.

Crit Rev Immunol. 1997;17(5-6):519-28. Review.

PMID:
9419439

Supplemental Content

Support Center